查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1892860

光學相干斷層掃描市場機會、成長促進因素、產業趨勢分析及預測（2025-2034年）

Optical Coherence Tomography Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 200 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2024 年全球光學相干斷層掃描市場價值為 18 億美元，預計到 2034 年將以 10.2% 的複合年成長率成長至 48 億美元。

光學相干斷層掃描市場 - IMG1

光學相干斷層掃描（OCT）是一種非侵入性成像方法，它利用低同調光產生生物組織的高解析度橫斷面影像。隨著研發工作的加速，旨在提高診斷清晰度、增加組織探測深度和加快影像擷取速度的技術不斷湧現，市場持續成長。這些進步推動了下一代診斷工具和治療監測系統在各種臨床環境中的應用。對小型攜帶式OCT設備的需求不斷成長，也影響OCT的發展趨勢，尤其是在醫療機構尋求便利的即時檢測解決方案，以服務鄉村診所、流動診所、家庭護理機構和門診中心等場所時。對行動性和工作流程效率的日益重視，促使製造商推出更精簡、方便用戶使用的成像系統，以適應更廣泛的臨床應用。早期檢測策略在眼部疾病診斷的應用日益廣泛，進一步增強了現代眼科護理對OCT技術的依賴。

市場範圍
起始年份 2024
預測年份 2025-2034
起始值 18億美元
預測值 48億美元
複合年成長率 10.2%

2024年，光譜域光學相干斷層掃描（SD-OCT）市佔率達76%。該細分市場佔據領先地位，主要原因是影響視網膜健康的慢性眼部疾病發病率不斷上升，從而推動了對精準、快速、高解析度成像的需求。 SD-OCT設備不僅常用於視網膜成像，也常用於評估眼前節、角膜狀況和視神經。其適應性強，可用於從疾病分期到治療後評估等各種臨床應用，使其成為全面視力評估中不可或缺的一部分。

2024年，桌上型OCT設備市佔率達到74.6%。這些系統仍然是眼科專業人士的首選，因為它們能夠提供穩定、高精度的成像，並與多種掃描技術相容。它們在眼科中心、專科機構和醫院科室的廣泛應用，得益於其能夠輔助分析青光眼進展、視網膜疾病和眼前節健康狀況。現代桌上型設備通常將多種成像技術整合於單一平台，從而打造高效的診斷工作站。

美國光學相干斷層掃描（OCT）市場預計在2024年達到6.31億美元，並在2034年達到16億美元。聯邦醫療保險（Medicare）和私人保險公司對OCT相關檢查的廣泛覆蓋，降低了患者和醫療機構的成本，從而促進了市場普及。 OCT的報銷範圍涵蓋多種應用，包括視神經分析、視網膜掃描和OCT血管造影，這鼓勵眼科診所將OCT更常規地整合到臨床工作流程中。

目錄

第1章：方法論與範圍

第2章：執行概要

第3章：行業洞察

  • 產業生態系分析
    • OCT組件的原始設備製造商（OEM）
    • 製造商
    • 監管機構
    • 經銷商和供應商
    • 最終用途
  • 產業影響因素
    • 成長促進因素
      • 眼部疾病日益增多
      • 光學相干斷層掃描技術的進步
      • 非侵入性診斷技術的應用日益普及
      • 提高新興經濟體的醫療保健投資和意識
    • 產業陷阱與挑戰
      • 治療費用高昂
      • 缺乏訓練有素、能夠操作和解讀OCT系統的專業人員。
    • 市場機遇
      • 人工智慧驅動的診斷演算法和自動化分析
      • 非處方藥在兒科和重症監護的應用日益增多
  • 成長潛力分析
  • 監管環境
    • 美國
    • 歐洲
    • 亞太地區
  • 技術格局
    • 當前技術趨勢
      • 用於深層組織可視化的掃頻源光學相干斷層掃描技術
      • 用於非侵入性血管成像的OCT血管造影
      • 用於即時診斷的攜帶式多模式八面體電腦斷層掃描（OCT）設備
    • 新興技術
      • 用於超靈敏成像的量子增強型光學相干斷層掃描技術
      • 用於即時像差校正的自適應光學整合
    • 3. 用於動態3D組織可視化的超高速OCT
  • 專利分析
    • 主要專利持有人和技術領導者
    • 專利到期分析及影響
    • 專利訴訟及糾紛
    • 地理專利保護策略
  • 2024年定價分析
  • 未來市場趨勢
    • 用於預測診斷的AI驅動型OCT平台
    • 基於雲端的OCT資料管理和遠距醫療整合
    • OCT應用拓展至眼科以外領域
  • 供應鏈和分銷分析
    • 原物料採購
    • 製造中心分析
    • 配銷通路映射和合作夥伴網路
    • 供應鏈脆弱性與風險緩解
  • 波特的分析
  • PESTEL 分析

第4章：競爭格局

  • 介紹
  • 公司市佔率分析
    • 全球的
    • 北美洲
    • 歐洲
    • 亞太地區
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 關鍵發展

第5章：市場估計與預測：依技術分類，2021-2034年

  • 光譜域光學相干斷層掃描
  • 掃頻源光學相干斷層掃描
  • 時域光學相干斷層掃描

第6章：市場估算與預測：依產品與服務分類，2021-2034年

  • 儀器
    • 桌上型OCT設備
    • 基於導管的OCT設備
    • 手持式OCT設備
    • 多普勒OCT設備
  • 組件更換服務、軟體許可和升級
  • 其他服務

第7章：市場估計與預測：依應用領域分類，2021-2034年

  • 眼科
  • 心臟病學
  • 皮膚科
  • 腫瘤學
  • 其他應用

第8章：市場估算與預測：依最終用途分類，2021-2034年

  • 醫院
  • 診斷影像中心
  • 門診手術中心
  • 其他最終用途

第9章：市場估計與預測：依地區分類，2021-2034年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國

第10章：公司簡介

  • Abbott Laboratories
  • Agfa-Gevaert
  • Canon
  • Carl Zeiss Meditec
  • Gentuity
  • Heidelberg Engineering
  • Huvitz
  • Metall Zug AG (Haag-Streit Group)
  • Moptim (Shenzhen Certainn Technology)
  • NIDEK
  • Nikon Corporation (Optos plc)
  • NinePoint Medical
  • Notal Vision
  • Novacam Technologies
  • OPTOPOL Technology
  • Philophos
  • Tomey
  • Topcon Corporation
  • TowardPi (Beijing) Medical Technology
  • Visionx
  • Vivolight
  • YSENMED
  • ZD medical
簡介目錄
Product Code: 13717

The Global Optical Coherence Tomography Market was valued at USD 1.8 billion in 2024 and is estimated to grow at a CAGR of 10.2% to reach USD 4.8 billion by 2034.

Optical Coherence Tomography Market - IMG1

OCT is a non-invasive imaging method that uses low-coherence light to produce highly detailed cross-sectional visuals of biological tissues. The market continues to grow as research and development efforts accelerate the launch of technologies aimed at improving diagnostic clarity, increasing tissue-depth reach, and speeding image acquisition. These advancements support the introduction of next-generation diagnostic tools and therapy-monitoring systems across various clinical environments. Rising demand for compact and portable OCT devices is also influencing development trends, especially as healthcare providers seek accessible solutions for point-of-care testing across rural practices, traveling clinics, home care facilities, and outpatient centers. The growing shift toward mobility and workflow efficiency is encouraging manufacturers to introduce more streamlined and user-friendly imaging systems designed for broader clinical use. Increasing adoption of early-detection strategies for major eye diseases further strengthens the reliance on OCT technology in modern ophthalmic care.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$1.8 Billion
Forecast Value$4.8 Billion
CAGR10.2%

The spectral domain OCT segment accounted for a 76% share in 2024. This segment holds a leading position due to rising incidences of chronic eye disorders that impact retinal health and drive the need for precise, fast, and high-resolution imaging. SD-OCT devices are frequently used not only for retinal interpretation but also for assessing the anterior segment, corneal conditions, and the optic nerve. Their adaptability for various clinical tasks, from disease staging to post-treatment evaluations, makes them integral to comprehensive vision assessment.

The tabletop OCT equipment segment held a 74.6% share in 2024. These systems remain the preferred choice for ophthalmic professionals because they offer stable, highly accurate imaging and compatibility with multiple scanning techniques. Their widespread use in eye centers, specialty facilities, and hospital departments is supported by their ability to assist in analyzing glaucoma progression, retinal disorders, and anterior segment health. Modern tabletop devices often combine multiple imaging technologies into a single platform, creating efficient diagnostic workstations.

United States Optical Coherence Tomography Market is projected to reach USD 631 million in 2024 and reach USD 1.6 billion by 2034. Substantial coverage from Medicare and private payers for OCT-related procedures enhances market adoption by lowering costs for both patients and providers. Reimbursement applies to several applications, including optic nerve analysis, retinal scanning, and OCT angiography, which encourages eye care practices to integrate OCT more routinely into clinical workflows.

Key companies participating in the Optical Coherence Tomography Market include Abbott Laboratories, Canon, Agfa-Gevaert, Gentuity, Huvitz, Heidelberg Engineering, Carl Zeiss Meditec, NIDEK, Metall Zug AG (Haag-Streit Group), Moptim (Shenzhen Certainn Technology), Nikon Corporation (Optos plc), Philophos, NotaLVision, NinePoint Medical, Novacam Technologies, OPTOPOL Technology, Topcon Corporation, Tomey, TowardPi (Beijing) Medical Technology, Visionx, Vivolight, YSENMED, and ZD Medical. Key strategies employed by major companies in the Optical Coherence Tomography Market focus on enhancing imaging performance, broadening clinical applications, and expanding product accessibility. Firms continue to invest in advanced light-source technologies and upgraded scanning algorithms to deliver sharper resolution and faster image capture. Many players are integrating multimodal imaging into unified systems to streamline diagnostic processes for clinicians. Collaborations with healthcare providers and academic research centers help refine device accuracy and support clinical validation.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Data mining sources
    • 1.3.1 Global
    • 1.3.2 Regional/country
  • 1.4 Base estimates and calculations
    • 1.4.1 Base year calculation
    • 1.4.2 Key trends for market estimation
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
  • 1.6 Forecast model
  • 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis
  • 2.2 Key market trends
    • 2.2.1 Regional trends
    • 2.2.2 Technology trends
    • 2.2.3 Product and services trends
    • 2.2.4 Application trends
    • 2.2.5 End use trends
  • 2.3 CXO perspectives: Strategic imperatives
    • 2.3.1 Key decision points for industry executives
    • 2.3.2 Critical success factors for market players
  • 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Original equipment manufacturers (OEMs) of OCT components
    • 3.1.2 Manufacturer
    • 3.1.3 Regulatory authorities
    • 3.1.4 Distributors and suppliers
    • 3.1.5 End use
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of eye disorders
      • 3.2.1.2 Advancements in OCT technology
      • 3.2.1.3 Rising adoption of non-invasive diagnostic techniques
      • 3.2.1.4 Increasing healthcare investments and awareness in emerging economies
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of therapies
      • 3.2.2.2 Shortage of skilled professionals trained to operate and interpret OCT systems
    • 3.2.3 Market opportunities
      • 3.2.3.1 AI-powered diagnostic algorithms and automated analysis
      • 3.2.3.2 Increasing applications of OTC in pediatric and critical care
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
    • 3.4.1 U.S.
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
  • 3.5 Technology landscape
    • 3.5.1 Current technological trends
      • 3.5.1.1 Swept source OCT for deep tissue visualization
      • 3.5.1.2 OCT angiography for non-invasive vascular mapping
      • 3.5.1.3 Portable and multimodal oct devices for point-of-care diagnostics
    • 3.5.2 Emerging technologies
      • 3.5.2.1 Quantum-enhanced OCT for ultra-sensitive imaging
      • 3.5.2.2 Adaptive optics integration for real-time aberration correction
    • 3.5.2. 3. Ultra-high-speed OCT for dynamic 3D tissue visualization
  • 3.6 Patent analysis
    • 3.6.1 Key patent holders and technology leaders
    • 3.6.2 Patent expiration analysis and impact
    • 3.6.3 Patent litigation and disputes
    • 3.6.4 Geographic patent protection strategies
  • 3.7 Pricing analysis, 2024
  • 3.8 Future market trends
    • 3.8.1 AI-driven OCT platforms for predictive diagnostics
    • 3.8.2 Cloud-based OCT data management and telemedicine integration
    • 3.8.3 Expansion of OCT applications beyond ophthalmology
  • 3.9 Supply chain and distribution analysis
    • 3.9.1 Raw material sourcing
    • 3.9.2 Manufacturing hub analysis
    • 3.9.3 Distribution channel mapping and partner networks
    • 3.9.4 Supply chain vulnerabilities and risk mitigation
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company market share analysis
    • 4.2.1 Global
    • 4.2.2 North America
    • 4.2.3 Europe
    • 4.2.4 Asia Pacific
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Key development

Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Spectral domain OCT
  • 5.3 Swept-source OCT
  • 5.4 Time domain OCT

Chapter 6 Market Estimates and Forecast, By Product and Services, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Instruments
    • 6.2.1 Tabletop OCT devices
    • 6.2.2 Catheter based OCT devices
    • 6.2.3 Handheld OCT devices
    • 6.2.4 Doppler OCT devices
  • 6.3 Component replacement services and software licensing and upgrade
  • 6.4 Other services

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Ophthalmology
  • 7.3 Cardiology
  • 7.4 Dermatology
  • 7.5 Oncology
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Diagnostic imaging centers
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Netherlands
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
  • 9.6 Middle East and Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 South Africa
    • 9.6.3 UAE

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Agfa-Gevaert
  • 10.3 Canon
  • 10.4 Carl Zeiss Meditec
  • 10.5 Gentuity
  • 10.6 Heidelberg Engineering
  • 10.7 Huvitz
  • 10.8 Metall Zug AG (Haag-Streit Group)
  • 10.9 Moptim (Shenzhen Certainn Technology)
  • 10.10 NIDEK
  • 10.11 Nikon Corporation (Optos plc)
  • 10.12 NinePoint Medical
  • 10.13 Notal Vision
  • 10.14 Novacam Technologies
  • 10.15 OPTOPOL Technology
  • 10.16 Philophos
  • 10.17 Tomey
  • 10.18 Topcon Corporation
  • 10.19 TowardPi (Beijing) Medical Technology
  • 10.20 Visionx
  • 10.21 Vivolight
  • 10.22 YSENMED
  • 10.23 ZD medical